학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 202건 | 목록
1~20
Academic Journal
Lecuelle, J.; Truntzer, C.; Taieb, J.; Laghi, L.; Greco, L.; Ilie, A.; Rageot, D.; Emile, J.F.; Bibeau, F.; Basile, D.; Derangère, V.; Lepage, C.; Ghiringhelli, F.
ESMO Real World Data and Digital Oncology. 10
Academic Journal
Perrichet A; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Lecuelle J; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Limagne E; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Thiefin M; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Bellio H; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Department of Medical Oncology, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Jacob P; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Aucagne R; Université de Bourgogne Europe, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, Epi2THM team, Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology, Dijon University Hospital, Dijon, France.; BioSanD, Inserm UMS 58, CRISPR Functional Genomics (CRIGEN) facility, Dijon, France.; Aznague A; Université de Bourgogne Europe, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, Epi2THM team, Dijon, France.; BioSanD, Inserm UMS 58, CRISPR Functional Genomics (CRIGEN) facility, Dijon, France.; Russo P; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Gaucher F; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Roussot N; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Department of Medical Oncology, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Yang X; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Vernet T; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Nuttin L; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France.; Ilie A; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France.; Rageot D; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Derangère V; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Huppe T; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Zippelius A; Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.; Routy B; University of Montreal Research Center (CRCHUM), Montreal, QC, Canada.; Truntzer C; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Chalmin F; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France.; Université de Bourgogne Europe, Dijon, France.; Ghiringhelli F; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France. fghiringhelli@cgfl.fr.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France. fghiringhelli@cgfl.fr.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France. fghiringhelli@cgfl.fr.; Université de Bourgogne Europe, Dijon, France. fghiringhelli@cgfl.fr.; Department of Medical Oncology, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France. fghiringhelli@cgfl.fr.; Genetic and Immunology Medical Institute, Dijon, France. fghiringhelli@cgfl.fr.; Rébé C; Cancer Biology Transfer Platform, Centre Régional De Lutte Contre Le Cancer Georges-François Leclerc, Dijon, France. crebe@cgfl.fr.; Center for Translational and Molecular medicine, Inserm UMR 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon, France. crebe@cgfl.fr.; BioSanD, Inserm UMS 58, Cancer Biology Transfer Platform facility, Dijon, France. crebe@cgfl.fr.; Université de Bourgogne Europe, Dijon, France. crebe@cgfl.fr.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Truntzer C; Cancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.; INSERM, LNC-UMR1231 Research Center, F-21000 Dijon, France.; Ouahbi D; Cancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.; Huppé T; Cancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.; Rageot D; Cancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.; INSERM, LNC-UMR1231 Research Center, F-21000 Dijon, France.; Ilie A; Cancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.; Molimard C; Department of Pathology, CHU Besançon, F-25000 Besançon, France.; Beltjens F; Department of Pathology, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.; Bergeron A; Department of Pathology, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.; Vienot A; Department of Medical Oncology, CHU Besançon, F-25000 Besançon, France.; Borg C; Department of Medical Oncology, CHU Besançon, F-25000 Besançon, France.; Monnien F; Department of Pathology, CHU Besançon, F-25000 Besançon, France.; Bibeau F; Department of Pathology, CHU Besançon, F-25000 Besançon, France.; Derangère V; Cancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.; INSERM, LNC-UMR1231 Research Center, F-21000 Dijon, France.; Ghiringhelli F; Cancer Biology Transfer Platform, Georges-François Leclerc Cancer Centre-Unicancer, F-21000 Dijon, France.; INSERM, LNC-UMR1231 Research Center, F-21000 Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, F-21000 Dijon, France.
Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Academic Journal
Thibaudin, M.; Roussot, N.; Hampe, L.; Daumoine, S.; Peroz, M.; Huppe, T.; Derangère, V.; Rageot, D.; Truntzer, C.; Fumet, J.D.; Ghiringhelli, F.; Vincent, J.; Tharin, Z.; Bengrine, L.; Bellio, H.; Burlot, C.; Schmitt, A.; Bertaut, A.; Rederstorff, E.; Simard, J.
In: Signal Transduction and Targeted Therapy . (Signal Transduction and Targeted Therapy, December 2025, 10(1))
Academic Journal
Rouland A; Department of Endocrinology, Diabetology and Nutrition, Dijon Bourgogne University Hospital, 21000 Dijon, France.; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France.; Gautier T; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France.; Denimal D; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France.; Department of Clinical Biochemistry, Dijon Bourgogne University Hospital, 21000 Dijon, France.; Duvillard L; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France.; Department of Clinical Biochemistry, Dijon Bourgogne University Hospital, 21000 Dijon, France.; Simoneau I; Department of Endocrinology, Diabetology and Nutrition, Dijon Bourgogne University Hospital, 21000 Dijon, France.; Rageot D; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France.; Vergès B; Department of Endocrinology, Diabetology and Nutrition, Dijon Bourgogne University Hospital, 21000 Dijon, France.; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France.; Bouillet B; Department of Endocrinology, Diabetology and Nutrition, Dijon Bourgogne University Hospital, 21000 Dijon, France.; INSERM Research Center U1231 CTM, University of Burgundy, 21000 Dijon, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101578790 Publication Model: Electronic Cited Medium: Print ISSN: 2218-1989 (Print) Linking ISSN: 22181989 NLM ISO Abbreviation: Metabolites Subsets: PubMed not MEDLINE
Academic Journal
Lecuelle, J.; Truntzer, C.; Taieb, J.; Laghi, L.; Greco, L.; Ilie, A.; Rageot, D.; Emile, J-f.; Bibeau, F.; Basile, D.; Derangere, V.; Lepage, C.; Ghiringhelli, F.
Academic Journal
Bertelli, Irene; Finocchiaro, Claudia; Rageot, Maxime; Ribechini, Erika; Mineo, Mario; Mengoli, Davide; Pannocchia, Cristiana Petrinelli; Starnini, Elisabetta; Vassanelli, Alice; Gibaja, Juan F.; Mazzucco, Niccolo
Academic Journal
Academic Journal
Roussot N; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Thibaudin M; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Fumet JD; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Daumoine S; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Hampe L; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Rébé C; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Limagne E; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Lagrange A; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Herreros V; Department of Interventional Radiology, Centre Georges-François Leclerc, Dijon, France.; Lecuelle J; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Mananet H; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Ilie A; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Rageot D; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Boidot R; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Goussot V; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Comte A; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Jacob P; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Beltjens F; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Bergeron A; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Charon-Barra C; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Arnould L; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Derangère V; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Ladoire S; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Truntzer C; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Ghiringhelli F; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Kalfeist L; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Ledys F; Université de Bourgogne Europe, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Petit S; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Poirrier C; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Kada Mohammed S; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Galland L; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Derangère V; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Ilie A; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Rageot D; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Aucagne R; Université de Bourgogne Europe, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology, Dijon University Hospital, Dijon, France.; INSERM UMS 58 BioSanD, CRISPR Functional Genomics (CRIGEN) Facility, Dijon, France.; Bellaye PS; Université de Bourgogne Europe, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Plateforme d'imagerie et de radiothérapie précliniques, INSERM UMS 58 BioSanD, Centre Georges-François Leclerc, Dijon, France.; Truntzer C; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Thibaudin M; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Rialland M; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Ghiringhelli F; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Limagne E; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Ladoire S; Université de Bourgogne Europe, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, INSERM UMS 58 BioSanD, Equipe Labellisée Ligue Contre le Cancer, Dijon, France.; INSERM UMR 1231, Center for Translational and Molecular Medicine (CTM), Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Academic Journal
Amicone, Silvia; Solard, Baptiste; Amelirad, Shelir; Azizi, Eghbal; Maritan, Lara; Rageot, Maxime; Berthold, Christoph; Radner, Karen
Academic Journal
Schoumacher C; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Derangère V; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; INSERM LNC-UMR1231 Research Center, TIRECS Team, Dijon, France.; Gaudillière-Le Dain G; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Huppe T; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Rageot D; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; INSERM LNC-UMR1231 Research Center, TIRECS Team, Dijon, France.; Ilie A; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Vienot A; Department of Medical Oncology, CHU Besançon, Besançon, France.; Borg C; Department of Medical Oncology, CHU Besançon, Besançon, France.; Monnien F; Department of Pathology, CHU Besançon, Besançon, France.; Bibeau F; Department of Pathology, CHU Besançon, Besançon, France.; Truntzer C; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; INSERM LNC-UMR1231 Research Center, TIRECS Team, Dijon, France.; Ghiringhelli F; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; INSERM LNC-UMR1231 Research Center, TIRECS Team, Dijon, France.; Genetic and Immunology Medical Institute, GIMI, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Academic Journal
Fournier C; Univ. Grenoble Alpes, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR, Grenoble, 5309, France; Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes, Grenoble, France. Electronic address: carole.fournier@univ-grenoble-alpes.fr.; Mercey-Ressejac M; Univ. Grenoble Alpes, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR, Grenoble, 5309, France.; Derangère V; INSERM U1231, Equipe TIRECS, Dijon, 21000, France; Université de Bourgogne, Dijon, 21000, France; Centre de Lutte contre le Cancer Georges François Leclerc, Plateforme de Transfert en Biologie du Cancer, Dijon, 21000, France.; Al Kadi A; Univ. Grenoble Alpes, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR, Grenoble, 5309, France.; Rageot D; INSERM U1231, Equipe TIRECS, Dijon, 21000, France; Université de Bourgogne, Dijon, 21000, France; Centre de Lutte contre le Cancer Georges François Leclerc, Plateforme de Transfert en Biologie du Cancer, Dijon, 21000, France.; Charrat C; Univ. Grenoble Alpes, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR, Grenoble, 5309, France.; Leroy A; Univ. Grenoble Alpes, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR, Grenoble, 5309, France.; Vollaire J; Univ. Grenoble Alpes, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR, Grenoble, 5309, France.; Josserand V; Univ. Grenoble Alpes, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR, Grenoble, 5309, France.; Escudé M; CEA, LETI, Technologies for Healthcare and Biology Division, Microtechnologies for Living Systems Interactions Research Unit, Univ. Grenoble Alpes, Grenoble, F-38000, France.; Escaich S; CEA, LETI, Technologies for Healthcare and Biology Division, Microtechnologies for Living Systems Interactions Research Unit, Univ. Grenoble Alpes, Grenoble, F-38000, France.; Ghiringhelli F; INSERM U1231, Equipe TIRECS, Dijon, 21000, France; Université de Bourgogne, Dijon, 21000, France; Centre de Lutte contre le Cancer Georges François Leclerc, Plateforme de Transfert en Biologie du Cancer, Dijon, 21000, France.; Decaens T; Univ. Grenoble Alpes, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR, Grenoble, 5309, France; Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes, Grenoble, France.; Navarro FP; CEA, LETI, Technologies for Healthcare and Biology Division, Microtechnologies for Living Systems Interactions Research Unit, Univ. Grenoble Alpes, Grenoble, F-38000, France.; Jouvin-Marche E; Univ. Grenoble Alpes, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR, Grenoble, 5309, France.; Marche PN; Univ. Grenoble Alpes, Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR, Grenoble, 5309, France.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Academic Journal
Lecuelle J; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Truntzer C; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France.; Basile D; Department of Medical Oncology, San Giovanni di Dio Hospital, Crotone, Italy.; Laghi L; Department of Medicine and Surgery, University of Parma, Parma, Italy; Molecular Gastroenterology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Greco L; Molecular Gastroenterology Laboratory, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Ilie A; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Rageot D; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Emile JF; Paris-Saclay University, Versailles SQY University (UVSQ), EA4340-BECCOH, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise Paré Hospital, Smart Imaging, Service de Pathologie, Boulogne, France.; Bibeau F; Service d'Anatomie et Cytologie Pathologiques, CHU Côte de Nacre, Normandie Université, Caen, France; Department of Pathology, Besançon University Hospital, Besançon, France.; Taïeb J; Institut du Cancer Paris Cancer Research for Personalized Medicine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Paris, France; Centre de Recherche des Cordeliers, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique, Sorbonne Université, Université Sorbonne Paris Cité, Université de Paris, Paris, France; Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP Centre, Université Paris Cité, Paris, France.; Derangere V; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France; University of Burgundy Franche-Comté, Dijon, France.; Lepage C; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; University of Burgundy Franche-Comté, Dijon, France; Fédération Francophone de Cancérologie Digestive, Centre de Randomisation Gestion Analyse, EPICAD LNC 1231, Dijon, France; Service d'Hépato-gastroentérologie et Oncologie digestive, CHU de Dijon, France.; Ghiringhelli F; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France; Genetic and Immunology Medical Institute, Dijon, France; University of Burgundy Franche-Comté, Dijon, France; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. Electronic address: fghiringhelli@cgfl.fr.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Academic Journal
Patrizi, Giulia; Rageot, Maxime; Cafisso, Sara; Pennetta, Antonio; Fiorini, Lucio; De Benedetto, Giuseppe Egidio; Spiteri, Cynthianne; Fiorentino, Girolamo
Academic Journal
Transplantation Proceedings. 38(7):2327-2329
Academic Journal
Vergès, B.; Florentin, E.; Baillot-Rudoni, S.; Monier, S.; Petit, J. M.; Rageot, D.; Gambert, P.; Duvillard, L.
Diabetologia: Clinical and Experimental Diabetes and Metabolism. August 2008 51(8):1382-1390
Academic Journal
Becher, Julia; Schoeman, Alex; Whitelaw, Gavin; Buckley, Stephen; Celliers, Jean-Pierre; Cafisso, Sara; Belser, Matthias; Rageot, Maxime; Spiteri, Cynthianne
Academic Journal
Chapusot, C; Martin, L; Mungra, N; Rageot, D; Bouvier, A M; Kopp, C Bonithon; Ponnelle, T; Faivre, J; Piard, F
Histopathology. Jul 01, 2003 43(1):40-47
Academic Journal
Diabetes and Metabolism. 36:A5-A5
검색 결과 제한하기
제한된 항목
[검색어] Rageot, D.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어